Evolutionary Genomics, Inc. (FNAM)

USD 0.0

(0.0%)

Total Debt Summary of Evolutionary Genomics, Inc.

  • Evolutionary Genomics, Inc.'s latest annual total debt in 2022 was 3.74 Million USD , down 0.0% from previous year.
  • Evolutionary Genomics, Inc.'s latest quarterly total debt in 2023 Q3 was - USD , down 0.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported annual total debt of 3.74 Million USD in 2021, up 66.7% from previous year.
  • Evolutionary Genomics, Inc. reported annual total debt of 2.24 Million USD in 2020, down 0.0% from previous year.
  • Evolutionary Genomics, Inc. reported quarterly total debt of - USD for 2023 Q1, down -100.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported quarterly total debt of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Total Debt Chart of Evolutionary Genomics, Inc. (2022 - 2009)

Historical Annual Total Debt of Evolutionary Genomics, Inc. (2022 - 2009)

Year Total Debt Total Debt Growth
2022 3.74 Million USD 0.0%
2021 3.74 Million USD 66.7%
2020 2.24 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%

Peer Total Debt Comparison of Evolutionary Genomics, Inc.

Name Total Debt Total Debt Difference
America Great Health 1.87 Million USD -100.171%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -1266.331%
Aridis Pharmaceuticals, Inc. 6.13 Million USD 38.927%
Biora Therapeutics, Inc. 47.42 Million USD 92.106%
Bio-Path Holdings, Inc. 113 Thousand USD -3213.05%
Better Therapeutics, Inc. 14.88 Million USD 74.84%
Calithera Biosciences, Inc. 1.66 Million USD -124.715%
Comera Life Sciences Holdings, Inc. 775.04 Thousand USD -383.034%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 19.44 Million USD 80.747%
Eloxx Pharmaceuticals, Inc. 13.38 Million USD 72.028%
Evelo Biosciences, Inc. 51.13 Million USD 92.679%
Finch Therapeutics Group, Inc. 30.12 Million USD 87.573%
Galera Therapeutics, Inc. 152.29 Million USD 97.542%
Innovation1 Biotech Inc. 228.99 Thousand USD -1534.831%
Kiromic BioPharma, Inc. 15.54 Million USD 75.913%
Molecular Templates, Inc. 12.23 Million USD 69.389%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD -53.791%
NexImmune, Inc. 68.8 Thousand USD -5340.781%
Orgenesis Inc. 22.62 Million USD 83.45%
Panbela Therapeutics, Inc. 5.19 Million USD 27.922%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 134.5 Million USD 97.217%
Statera Biopharma, Inc. 16.26 Million USD 76.977%
TRACON Pharmaceuticals, Inc. 968 Thousand USD -286.751%
Trevena, Inc. 35.23 Million USD 89.374%
Vaxxinity, Inc. 15.16 Million USD 75.318%
Vaccinex, Inc. 247 Thousand USD -1415.687%
Vicapsys Life Sciences, Inc. 353.86 Thousand USD -957.95%
Viracta Therapeutics, Inc. 25.55 Million USD 85.351%
ZIVO Bioscience, Inc. 346.34 Thousand USD -980.939%